
- ASX-listed Health and Plant Protein (HPP) is among just a handful of companies to spot the upcoming boom in plant-based food alternatives
- The Good Food Institute (GFI) estimates that plant-based products are growing at five times the rate of typical food growth in the United States
- From beverages to dairy alternatives and even plant-based meat alternatives, the industry is booming as vegan lifestyles become more mainstream
- While HPP is focussing on the plant-based food market as a whole, the company has also made a savvy investment in macadamia nuts
- Macadamias are the most expensive nut in the world, and HPP helps produce a premium macadamia product through its Hawaiian subsidiary, MacFarms
- On top of this, HPP has recently taken a controlling interest in the U.S.-based LAVVA brand alongside investment partner S2G Ventures
- LAVVA sells plant-based yoghurt and milk alternatives and already has its products stocked in several major U.S. retailers
- Health and Plant Protein is set to profit from an inevitable change in the foods people consume; it’s up to investors to seize the opportunity before it’s too late
Subscribe to our newsletter